Furthermore, in these in vivo and in vitro oral cancer models, the activity of fenofibrate affected hexokinase II, PDH, and VDAC protein levels, as indicated in Figure 2A [125,126,127]. This evidence concerns the gene VDAC1 and lip and oral cavity carcinoma.